Amneal’s IPX-203 Increases ‘Good’ ON Time For Parkinson’s Patients

OFF Time Was Reduced With Longer-Acting Levodopa Product

 
• By Mandy Jackson
Notebook with PARKINSON'S DISEASE on white wooden background
IPX-203 could be a bigger seller than Amneal's legacy extended-release drug Rytary • Source: Alamy

More from Clinical Trials

More from R&D